GlassScriptPhysician profile
Bobby Swinney
NPI 1528421484
$9,615.46
in general payments reported to CMS, 2019-2025
43 companies · $1,005 in 2025
The $1,005 reported for 2025 was more than what 85% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.26 · 2020: $1,061 · 2021: $2,485 · 2022: $1,805 · 2023: $1,359 · 2024: $1,827 · 2025: $1,005.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,191.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,561.99 | 2020-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $1,425.98 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Viiv Healthcare Company | $1,409.25 | 2020-2025 | Dovato, Cabenuva |
| Abbvie INC. | $1,178.69 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Novo Nordisk INC | $919.89 | 2020-2025 | Wegovy, Rybelsus, Ozempic |
| Lilly USA, LLC | $666.47 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Gilead Sciences, INC. | $308.95 | 2020-2025 | |
| Pfizer INC. | $279.40 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $173.47 | 2021-2025 | Ofev, Jardiance |
| Corcept Therapeutics | $171.17 | 2022-2025 | Korlym |
| Renalytix Ai, INC. | $150.25 | 2022-2025 | Kidneyintelx Blood Collection Convenience Kit |
| Janssen Pharmaceuticals, INC | $119.76 | 2019-2025 | Spravato |
| Daiichi Sankyo INC. | $118.24 | 2020-2021 | |
| Astellas Pharma US INC | $103.28 | 2020-2021 | |
| Allergan, INC. | $96.94 | 2019-2020 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bobby Swinney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.